Effect of LY2062430 on the Progression of Alzheimer's Disease

Clinical trial NCT00905372 · COMPLETED

Trial details

NCT number: NCT00905372
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2009-05-01
Primary completion: 2012-04-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.